Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder

Christopher Melani, Elaine S. Jaffe, Wyndham H. Wilson

Blood (2020) 135 (16): 1344–1352.

https://doi.org/10.1182/blood.2019000933

Published: 2020

Journal Articles

Ibrutinib Maintenance after Chemoimmunotherapy Is Feasible and Results in Excellent Progression-Free and Overall Survival in Patients with Detectable MRD after Chemoimmunotherapy

Nayara Ribeiro Guedes, MD, Ana Rita Da Fonseca, MD, Thiago Xavier Carneiro, MD PhD, Vinicius Campos de Molla, MD, Rodrigo Santucci Silva, MD, Sérgio Costa Fortier, MD, Vera Lucia de Piratininga Figueiredo, MD, Larissa Ommati, MD, Valeria Buccheri, MD PhD, Gislaine Borba Oliveira, MD, Leila Martins Perobelli, MD, Fernando Sergio Blumm Ferreira, MD, Matheus Vescovi, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 1764.

https://doi.org/10.1182/blood-2019-125626

Published: 2019

Journal Articles

Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis

Christopher Melani, MD, Mark Roschewski, MD, Stefania Pittaluga, MD PhD, Jeffrey Cohen, MD, Andrea Nicole Lucas, RN, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD PhD

Blood (2018) 132 (Supplement 1): 785.

https://doi.org/10.1182/blood-2018-99-116707

Published: 2018

Journal Articles

Characteristics, Treatments, and Outcomes of Patients with Lymphomatoid Granulomatosis—MD Anderson Cancer Center Experience

Preetesh Jain, MBBS,MDDM,PhD, Rashmi Kanagal-Shamanna, MD, Ahmad Ghorab, MDMSc, Loretta Nastoupil, MD, Luis E. Fayad, Jeffrey Medeiros, MD, Shimin Hu, Sattva S. Neelapu, MD, Jason R. Westin, MD, Yasuhiro Oki, MD, Michael Wang, MD, Nathan H. Fowler, MD

Blood (2017) 130 (Supplement 1): 2852.

https://doi.org/10.1182/blood.V130.Suppl_1.2852.2852

Published: 2017

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation

Melinda Mezo, Chad C. Bjorklund, Lilia Weiss, Neil Minton, John Freeman

Blood (2015) 126 (23): 5372.

https://doi.org/10.1182/blood.V126.23.5372.5372

Published: 2015

Journal Articles

PD-L1 and PD1 Expression in Lymphomas

Zoran Gatalica, MD PhD, Nurija Bilalovic, MD PhD, Semir Vranic, MD PhD, David Arguello, MD, Sandeep Reddy, MD, Nilanjan Ghosh, MD PhD

Blood (2015) 126 (23): 3899.

https://doi.org/10.1182/blood.V126.23.3899.3899

Published: 2015

Journal Articles

The Epstein-Barr Virus Lytic Protein BZLF1 As a Candidate Target Antigen for Vaccine Development

Alex S. Hartlage, Tom Liu, PhD, John T. Patton, Sabrina L Garman, Xiaoli Zhang, PhD MS, Habibe Kurt, MD, Gerard Lozanski, MD, Mark E Lustberg, MD PhD, Michael A. Caligiuri, MD, Robert A. Baiocchi, MD PhD

Blood (2014) 124 (21): 4144.

https://doi.org/10.1182/blood.V124.21.4144.4144

Published: 2014

Journal Articles

Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder

James Dugan, MD MS, Bradley M. Haverkos, MD MPH, Ludmila Katherine Martin, MD, Marisa F. Martin, Mark E Lustberg, MD PhD, John T. Patton, PhD, Gerard Nuovo, MD, Fengting Yan, MD, PhD, Robert Cavaliere, MD, Shannon C. Kenney, MD, Joyce Fingeroth, MD, Gerard Lozanski, MD, Juan Carlos Ramos, MD, Pierluigi Porcu, MD, Michael A. Caligiuri, MD, Robert A. Baiocchi, MD PhD

Blood (2014) 124 (21): 1750.

https://doi.org/10.1182/blood.V124.21.1750.1750

Published: 2014

Journal Articles

Lymphomatoid Granulomatosis: A Clinicopathologic Study of a Series of Cases in a Single Institution

Julio C Chavez, MD, Ling Zhang, MD, Elizabeth M. Sagatys, MD, Lubomir Sokol, MD, PhD, Lynn Moscinski, MD, Eduardo M. Sotomayor, Bijal D. Shah, MD

Blood (2011) 118 (21): 4960.

https://doi.org/10.1182/blood.V118.21.4960.4960

Published: 2011

Journal Articles

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Ludmila Katherine Martin, MD, Mark E Lustberg, MD, PhD, Fengting Yan, M.D., Ph.D., John T. Patton, Pierluigi Porcu, MD, Gerard Nuovo, M.D., Robert Cavaliere, MD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 3067.

https://doi.org/10.1182/blood.V118.21.3067.3067

Published: 2011

Journal Articles

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Kieron Dunleavy, MD, Pratip Chattopadhyay, PhD, Junichi Kawada, Sara Calattini, Emma Gostick, PhD, David Price, MD, PhD, Mario Roderer, PhD, Jeffrey Cohen, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, John E Janik, MD, Elaine S Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 963.

https://doi.org/10.1182/blood.V116.21.963.963

Published: 2010

Journal Articles

Possible Perforin-Munc13-4 Gene-Gene Interaction in Familial Hemophagocytic Lymphohistiocytosis

Gunay Balta, Hamza Okur, Nurten Akarsu, Sule Unal, Cigdem Altay, Aytemiz Gurgey

Blood (2008) 112 (11): 4643.

https://doi.org/10.1182/blood.V112.11.4643.4643

Published: 2008

Journal Articles

The Role of Mig, the Monokine Induced by Interferon-γ, and IP-10, the Interferon-γ–Inducible Protein-10, in Tissue Necrosis and Vascular Damage Associated With Epstein-Barr Virus-Positive Lymphoproliferative Disease

Julie Teruya-Feldstein, Elaine S. Jaffe, Parris R. Burd, Hirokazu Kanegane, Douglas W. Kingma, Wyndham H. Wilson, Dan L. Longo, Giovanna Tosato

Blood (1997) 90 (10): 4099–4105.

https://doi.org/10.1182/blood.V90.10.4099

Published: 1997

NARROW

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder

Ibrutinib Maintenance after Chemoimmunotherapy Is Feasible and Results in Excellent Progression-Free and Overall Survival in Patients with Detectable MRD after Chemoimmunotherapy

Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis

Characteristics, Treatments, and Outcomes of Patients with Lymphomatoid Granulomatosis—MD Anderson Cancer Center Experience

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation

PD-L1 and PD1 Expression in Lymphomas

The Epstein-Barr Virus Lytic Protein BZLF1 As a Candidate Target Antigen for Vaccine Development

Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder

Lymphomatoid Granulomatosis: A Clinicopathologic Study of a Series of Cases in a Single Institution

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Possible Perforin-Munc13-4 Gene-Gene Interaction in Familial Hemophagocytic Lymphohistiocytosis

The Role of Mig, the Monokine Induced by Interferon-γ, and IP-10, the Interferon-γ–Inducible Protein-10, in Tissue Necrosis and Vascular Damage Associated With Epstein-Barr Virus-Positive Lymphoproliferative Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only